In August 2020, Russia approved its homegrown coronavirus vaccine Sputnik V, months ahead of rival programs in the west. Episode 8 of The Pharma Letter Podcast 14 December 2021
In the early days of the coronavirus pandemic, many drugmakers saw major share price declines as investors got to grips with the likely impact on prescribing, d 16 November 2021
High-risk MDS, often referred to as preleukemia, is a chronic form of blood cancer with a significant level of unmet medical need. While no new therapies have b 1 October 2021
All signs point to an M&A boom in late 2021 and throughout 2022. In this episode, Lance Minor, principal and national co-leader of the life sciences practice at 1 September 2021
For many years, industry commentators have observed that there could be huge untapped therapeutic potential for psychedelics, should the correct development pat 18 August 2021
The USA continues to wrestle with the legacy of an epidemic of opioid abuse.believed to have cost the lives of over half a million people through overdose.In th 22 July 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.